Literature DB >> 8930726

Composites of bone morphogenetic protein (BMP) and type IV collagen, coral-derived coral hydroxyapatite, and tricalcium phosphate ceramics.

T Gao1, T S Lindholm, A Marttinen, M R Urist.   

Abstract

Few studies have been performed to investigate the characteristics of native Bone Morphogenetic Protein (BMP). We derived 5.85 g of native moose BMP from 102 kg of fresh moose bone and performed chromatographic studies to characterise its structure. We found the BMP molecule to have a molecular weight of 11-700 kDa. To investigate the ideal local delivery system for BMP we used porous discs as a carrier. These were implanted into 132 mice. The volume of new bone formed was evaluated by means of histological specimens, radiographs and isotope studies. The best results were obtained by implanting porous discs (coral and ceramic) with type IV collagen and BMP. We suggest that this is the best delivery system for future experiments regarding the acton of BMP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930726     DOI: 10.1007/s002640050086

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  3 in total

1.  The controlled resorption of porous alpha-tricalcium phosphate using a hydroxypropylcellulose coating.

Authors:  Makoto Kitamura; Chikara Ohtsuki; Haruna Iwasaki; Shin-Ichi Ogata; Masao Tanihara; Toshiki Miyazaki
Journal:  J Mater Sci Mater Med       Date:  2004-10       Impact factor: 3.896

2.  Influence of ethylene oxide sterilization on the activity of native reindeer bone morphogenetic protein.

Authors:  T Pekkarinen; O Hietala; T S Lindholm; P Jalovaara
Journal:  Int Orthop       Date:  2003-11-15       Impact factor: 3.075

3.  Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis.

Authors:  Arthur A Decarlo; Maria Belousova; April L Ellis; Donald Petersen; Hernan Grenett; Patrick Hardigan; Robert O'Grady; Megan Lord; John M Whitelock
Journal:  BMC Biotechnol       Date:  2012-09-11       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.